Marley Spoon AG (MMM.AX)

Overall impact
C (53)

Commentary

Marley Spoon AG is an average overall performer. With a 'C' rating of 52.9 for overall impact (47th percentile compared to all companies), Marley Spoon AG ranks 54th out of 140 industry peers, behind DO & CO AG, Dts8 Coffee Company, Jollibee Foods and 50 others, and ahead of Bid Corporation, Raising Cane's, Arcos Dorados and 83 others. On top material causes for Marley Spoon AG's industry (Hotels, Restaurants & Leisure), Marley Spoon AG performs well in Accountable Institutions (88.4 score), Accountable Institutions (88.4), Accountable Institutions (88.4) and 6 other causes where it received an 'A' score and performs poorly in Child and Maternal Health (15.7 score), Child and Maternal Health (27.2), Child and Maternal Health (19.6) and 54 other causes where it received a 'D' or 'F' score.
Screens
Fur
Impact
Cause MMM.AX
Peer rank
Overall impact

Log in to view this information

Screens
Fur
Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
1,483
Sector
Consumer Discretionary
Industry
Hotels, Restaurants & Leisure
Sub-industry
Restaurants
SASB industry
Restaurants
Headquarters
Germany
Share classes
MMM.AX
Description
Marley Spoon SE, together with its subsidiaries, engages in the provision of subscription-based weekly meal kit services in the United States, Australia, Austria, Belgium, Germany, and the Netherlands. The company creates and delivers its original recipe meal kits, including ingredients and recipe card directly to customers for them to prepare and cook, as well as offers ready-to-heat meals. It sells its products under the Marley Spoon, Dinnerly, Chefgood, and BistroMD brands. The company was incorporated in 2014 and is headquartered in Berlin, Germany. Marley Spoon SE operates as a subsidiary of Marley Spoon Group SE.
Material causes
Ethos considers the following causes material for Marley Spoon AG, based on its industry sub-industry Restaurants. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.